由青霉素类软膏制成的真菌抗生素。
The use of antibiotics disturbed the symbiosis between bacteria and fungi.
目的：了解青霉素类口服制剂的安全性问题。
Objective: To understand the safety of oral penicillins agents.
目前，青霉素类临床上应用最广，发生过敏性反应也最为多见。
At present, the penicillin class on clinical applies broadly, has the allergic reaction also most to see.
在致敏药物中，以抗生素及中药多见，尤其是口服青霉素类常见。
The antibiotics and Chinese Traditional Medicines, especially oral penicillin was the most common among the causative drugs.
对青霉素类及其含酶抑制药物的耐药率略有波动，大致呈下降趋势。
The resistance of Abi to penicillins and to their inhibitedcompounds fluctuated slightly and downtrended more or less.
结果1990年至1999年细菌L型常见菌株耐药性逐年上升，特别是青霉素类大部耐药；
Results From 1990 to 1999, the drug resistance to common L-form bacteria was rising year after year, especially to penicillins.
此项发现意味着抗生素类药（比如青霉素）可能渗入周围环境并激发了抗药细菌在海洋里进化和倍增。
The finding suggests antibiotics such as penicillin may be leaching into the environment and spurring drug-resistant bacteria to evolve and multiply in the oceans.
除类杆菌感染以外，吸入的细菌差不多都对青霉素敏感，在获悉细菌药敏试验报告之前，可先选用青霉素及灭滴灵治疗。
The bacteria, apart from bacteroides, are nearly all penicillin sensitive and crystalline penicillin with metronidazole are the antibiotics of choice initially until sensitivities are known.
对严重感染者用抗菌素(青霉素)或磺胺类药剂，或两者合用，以预防并发症。
Antibiotics (penicillin) or sulfonamides or both are prescribed in severe infections to prevent complications.
有5 0 .0 %的肠球菌感染不能用青霉素或粘肽类与氨基糖苷类联合用药。
The combined therapy with penicillins or vancomycin plus an aminoglycoside can not be used in 50.0% enterococci infection.
有5 0 .0 %的肠球菌感染不能用青霉素或粘肽类与氨基糖苷类联合用药。
The combined therapy with penicillins or vancomycin plus an aminoglycoside can not be used in 50.0% enterococci infection.
应用推荐